| Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis RL Levine, M Wadleigh, J Cools, BL Ebert, G Wernig, BJP Huntly, ... Cancer cell 7 (4), 387-397, 2005 | 3928 | 2005 |
| Repair pathway choices and consequences at the double-strand break R Ceccaldi, B Rondinelli, AD D’Andrea Trends in cell biology 26 (1), 52-64, 2016 | 1667 | 2016 |
| Biallelic Inactivation of BRCA2 in Fanconi Anemia NG Howlett, T Taniguchi, S Olson, B Cox, Q Waisfisz, C de Die-Smulders, ... Science 297 (5581), 606-609, 2002 | 1484 | 2002 |
| Cloning of cDNA for the major DNA-binding protein of the erythroid lineage through expression in mammalian cells SF Tsai, DIK Martin, LI Zon, AD D'Andrea, GG Wong, SH Orkin Nature 339 (6224), 446-451, 1989 | 1076 | 1989 |
| Expression cloning of the murine erythropoietin receptor AD D'Andrea, HF Lodish, GG Wong cell 57 (2), 277-285, 1989 | 1042 | 1989 |
| The Fanconi anaemia/BRCA pathway AD D'Andrea, M Grompe Nature Reviews Cancer 3 (1), 23-34, 2003 | 1027 | 2003 |
| Homologous-recombination-deficient tumours are dependent on Polθ-mediated repair R Ceccaldi, JC Liu, R Amunugama, I Hajdu, B Primack, MIR Petalcorin, ... Nature 518 (7538), 258-262, 2015 | 921 | 2015 |
| Homologous recombination deficiency: exploiting the fundamental vulnerability of ovarian cancer PA Konstantinopoulos, R Ceccaldi, GI Shapiro, AD D'Andrea Cancer discovery 5 (11), 1137-1154, 2015 | 914 | 2015 |
| Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair A Smogorzewska, S Matsuoka, P Vinciguerra, ER McDonald, KE Hurov, ... Cell 129 (2), 289-301, 2007 | 834 | 2007 |
| How the fanconi anemia pathway guards the genome GL Moldovan, AD D'Andrea Annual review of genetics 43 (1), 223-249, 2009 | 783 | 2009 |
| The Fanconi anaemia pathway: new players and new functions R Ceccaldi, P Sarangi, AD D'Andrea Nature reviews Molecular cell biology 17 (6), 337-349, 2016 | 752 | 2016 |
| Disruption of the Fanconi anemia–BRCA pathway in cisplatin-sensitive ovarian tumors T Taniguchi, M Tischkowitz, N Ameziane, SV Hodgson, CG Mathew, ... Nature medicine 9 (5), 568-574, 2003 | 723 | 2003 |
| The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway SMB Nijman, TT Huang, AMG Dirac, TR Brummelkamp, RM Kerkhoven, ... Molecular cell 17 (3), 331-339, 2005 | 703 | 2005 |
| Chromatin remodeling at DNA double-strand breaks BD Price, AD D’Andrea Cell 152 (6), 1344-1354, 2013 | 675 | 2013 |
| Regulation of monoubiquitinated PCNA by DUB autocleavage TT Huang, SMB Nijman, KD Mirchandani, PJ Galardy, MA Cohn, W Haas, ... Nature cell biology 8 (4), 341-347, 2006 | 675 | 2006 |
| Cooperation of Stat2 and p300/CBP in signalling induced by interferon-α S Bhattacharya, R Eckner, S Grossman, E Oldread, Z Arany, A D'Andrea, ... Nature 383 (6598), 344-347, 1996 | 670 | 1996 |
| Association of polymerase e–mutated and microsatellite-instable endometrial cancers with neoantigen load, number of tumor-infiltrating lymphocytes, and expression of PD-1 and PD-L1 BE Howitt, SA Shukla, LM Sholl, LL Ritterhouse, JC Watkins, S Rodig, ... JAMA oncology 1 (9), 1319-1323, 2015 | 668 | 2015 |
| Somatic ERCC2 Mutations Correlate with Cisplatin Sensitivity in Muscle-Invasive Urothelial Carcinoma EM Van Allen, KW Mouw, P Kim, G Iyer, N Wagle, H Al-Ahmadie, C Zhu, ... Cancer discovery 4 (10), 1140-1153, 2014 | 637 | 2014 |
| Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade … KC Strickland, BE Howitt, SA Shukla, S Rodig, LL Ritterhouse, JF Liu, ... Oncotarget 7 (12), 13587, 2016 | 630 | 2016 |
| Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway H Kim, AD D'Andrea Genes & development 26 (13), 1393-1408, 2012 | 604 | 2012 |
